Patient-Reported Outcomes for the Assessment of Sexual Health AmongPatients Affected by Inflammatory Bowel Disease

Daniela Pugliese, L Parisio, Tommaso Schepis, Giuseppe Privitera, Valentin Calvez, Antonio Gasbarrini, Alessandro Armuzzi
In: Reviews on Recent Clinical Trials · 2022 · vol. 17(4) , pp. 250–258 · doi:10.2174/1574887117666220630114054 · PMID:35786192 · W4283799511
review OA: closed CC0 ⤵ 1 in-corpus citation
Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This review explores patient-reported outcomes for assessing sexual health in inflammatory bowel disease patients, summarizing evidence on sexual dysfunction and the utility of PROs in this population.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Patients affected by inflammatory bowel disease (IBD) frequently report impaired quality of sexual life and complain of sexual dysfunctions. Both disease-specific features and psychological factors can be held responsible for these conditions. However, sexuality and all matters relating to sexual health are often wrongfully considered unrelated to IBD and, therefore, overlooked during medical visits. To overcome these difficulties and to best assess patients' perceptions about their sexual health status, the use of patient-reported outcomes (PROs) could represent a valid strategy. In real-world studies, several non-IBD specific questionnaires, exploring different domains of sexuality, have been applied and validated for the IBD population. This review summarizes the available evidence on sexual health among IBD patients and the data supporting the application of PROs to screen the quality of sexual life, as well as the rate and types of sexual dysfunctions, among IBD patients.
Full text 3,521 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Patients affected by inflammatory bowel disease (IBD) frequently report impaired quality of sexual life and complain of sexual dysfunctions. Both disease-specific features and psychological factors can be held responsible for these conditions. However, sexuality and all matters relating to sexual health are often wrongfully considered unrelated to IBD and, therefore, overlooked during medical visits. To overcome these difficulties and to best assess patients’ perceptions about their sexual health status, the use of patient-reported outcomes (PROs) could represent a valid strategy. In real-world studies, several non-IBD specific questionnaires, exploring different domains of sexuality, have been applied and validated for the IBD population. This review summarizes the available evidence on sexual health among IBD patients and the data supporting the application of PROs to screen the quality of sexual life, as well as the rate and types of sexual dysfunctions, among IBD patients.

Keywords

Inflammatory bowel disease, sexual health, sexual dysfunction, patient-reported outcomes, IBD patients, sexual life. [http://dx.doi.org/10.1080/08964289.2019.1676193] [PMID: 34048329] [http://dx.doi.org/10.1053/j.sempedsurg.2017.10.003] [PMID: 29126502] [http://dx.doi.org/10.1007/s00535-012-0700-2] [PMID: 23124604] [http://dx.doi.org/10.1093/ecco-jcc/jjx100] [PMID: 28981625] [http://dx.doi.org/10.1093/ecco-jcc/jjab043] [http://dx.doi.org/10.1016/j.cgh.2018.12.021] [PMID: 30583048] [http://dx.doi.org/10.1111/apt.13001] [PMID: 25348809] [http://dx.doi.org/10.1055/s-2000-14868] [PMID: 10820859] [http://dx.doi.org/10.1016/j.crohns.2014.04.013] [PMID: 24856864] [http://dx.doi.org/10.1111/j.1365-2036.2011.04871.x] [PMID: 21999576] [http://dx.doi.org/10.1136/gutjnl-2011-300049] [http://dx.doi.org/10.1016/j.gastrohep.2018.05.009] [PMID: 29937084] [http://dx.doi.org/10.1046/j.1525-1497.2001.016009606.x] [PMID: 11556941] [http://dx.doi.org/10.3748/wjg.v25.i36.5423] [PMID: 31576090] [http://dx.doi.org/10.1016/j.crohns.2013.01.018] [PMID: 23453888] [http://dx.doi.org/10.1111/codi.15375] [PMID: 32961618] [http://dx.doi.org/10.1007/s00384-021-03958-y] [PMID: 34050786] [http://dx.doi.org/10.1038/ijir.2009.44] [PMID: 19759542] [http://dx.doi.org/10.1093/ibd/izy345] [http://dx.doi.org/10.1007/s00595-013-0505-9] [http://dx.doi.org/10.5604/01.3001.0014.5408] [PMID: 33729170] [http://dx.doi.org/10.1111/j.1463-1318.2005.00895.x] [http://dx.doi.org/10.1016/S0090-4295(97)00238-0] [PMID: 9187685] [http://dx.doi.org/10.1080/009262300278597] [http://dx.doi.org/10.5152/tjg.2019.18676] [PMID: 31767548] [http://dx.doi.org/10.1111/j.1743-6109.2007.00749.x] [PMID: 18208501] [http://dx.doi.org/10.1080/00926230591006502] [PMID: 16169822] [http://dx.doi.org/10.1111/j.1743-6109.2012.02995.x] [http://dx.doi.org/10.1016/j.jsxm.2018.09.015] [PMID: 30539735] [http://dx.doi.org/10.1016/0165-1781(88)90106-0] [PMID: 3406241] [http://dx.doi.org/10.1007/BF01541816] [PMID: 7872859] [http://dx.doi.org/10.1080/00926230290001448] [PMID: 12082670] [http://dx.doi.org/10.1080/009262300278623] [PMID: 10693114] [http://dx.doi.org/10.1111/jsm.12913] [PMID: 26054013] [http://dx.doi.org/10.1016/j.cgh.2006.10.018.] [http://dx.doi.org/10.1093/ibd/izy397] [PMID: 30726913] [http://dx.doi.org/10.1093/ecco-jcc/jjaa038] [http://dx.doi.org/10.1007/s10620-018-5021-8] [PMID: 29564672] [http://dx.doi.org/10.1093/ibd/izz185] [http://dx.doi.org/10.1037/h0047358] [PMID: 13813058] [http://dx.doi.org/10.1093/ibd/izx053] [PMID: 29361102]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (44)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK